glenmark pharamceuticals
Jump to
13 Results Found
  • Glenmark Pharma shares fall as India's drug regulator sends notice on overpricing Jul 20, 2020 12:10 PM IST

    Glenmark Pharma shares fall as India's drug regulator sends notice on overpricing

    The Mumbai-based company reduced the price of FabiFlu to 75 rupees ($1.00) per tablet last week for restricted emergency use in patients with mild-to-moderate COVID-19 symptoms in India.

  • Coronavirus pandemic | Glenmark Pharma cuts price of favipiravir by 27% to Rs 75/tablet Jul 13, 2020 12:40 PM IST

    Coronavirus pandemic | Glenmark Pharma cuts price of favipiravir by 27% to Rs 75/tablet

    Glenmark completed the phase 3 clinical trial with Favipiravir (FabiFlu) in mild to moderate COVID-19 patients in India.

  • US charges generic drug firm Glenmark with price-fixing Jul 01, 2020 09:52 AM IST

    US charges generic drug firm Glenmark with price-fixing

    Glenmark allegedly conspired with pharmaceutical maker Apotex Corp and other generic drug companies to increase the prices of cholesterol medication pravastatin and other generic drugs, the department said.

  • Glenmark gets USFDA's final nod for Deferasirox tablets Jan 07, 2020 10:44 AM IST

    Glenmark gets USFDA's final nod for Deferasirox tablets

    Deferasirox is used to treat high levels of iron in the body caused by multiple blood transfusions.

  • Glenmark recalls over 2 lakh cartons of product in US Nov 10, 2019 12:05 PM IST

    Glenmark recalls over 2 lakh cartons of product in US

    According to the latest Enforcement Report by the US Food and Drug Administration (USFDA), Glenmark Pharmaceuticals Inc USA is recalling the product in various strengths which was manufactured at company's Goa manufacturing facility.

  • Glenmark Pharma down over 6%, hits 52-weeks low as FDA issues CRL for Ryaltris Jun 24, 2019 10:36 AM IST

    Glenmark Pharma down over 6%, hits 52-weeks low as FDA issues CRL for Ryaltris

    Glenmark said it will continue to pursue regulatory approval for Ryaltris and work closely with the FDA to determine the appropriate next steps

  • Glenmark gets USFDA nod for generic Westcort cream Oct 15, 2018 04:00 PM IST

    Glenmark gets USFDA nod for generic Westcort cream

    The product is a generic version of Sun Pharmaceutical Industries' Westcort Cream in the same strength, it added.

  • Buy Glenmark Pharmaceuticals; target of Rs 840: Axis Direct Aug 07, 2017 03:11 PM IST

    Buy Glenmark Pharmaceuticals; target of Rs 840: Axis Direct

    Axis Direct is bullish on Glenmark has recommended buy rating on the stock with a target price of Rs 840 in its research report dated August 02, 2017.

  • Growth a concern for Glenmark; Titan has become jewellery stock: Udayan Mukherjee May 15, 2017 11:34 AM IST

    Growth a concern for Glenmark; Titan has become jewellery stock: Udayan Mukherjee

    Titan's EBIT from the jewellery business is ten times the EBIT from watches plus eyewear business put together, said Udayan Mukherjee.

  • Glenmark posts Rs 184 crore net profit in Q4; earnings below analyst estimates May 11, 2017 10:39 PM IST

    Glenmark posts Rs 184 crore net profit in Q4; earnings below analyst estimates

    The profits were impacted due to an Rs 81 crore exceptional item, high expenses and decline in sales across Europe, Latin America, and other markets. The expenses shot up 13.6 percent to Rs 2152 crore on sequential basis.

  • Buy Glenmark Pharmaceuticals ; target of Rs 1100: Axis Direct Mar 29, 2017 04:48 PM IST

    Buy Glenmark Pharmaceuticals ; target of Rs 1100: Axis Direct

    Axis Direct is bullish on Glenmark Pharmaceuticals has recommended buy rating on the stock with a target price of Rs 1100 in its research report dated March 24, 2017.

  • Sell Tata Motors, Glenmark Pharma; buy Colgate Palmolive: Sudarshan Sukhani Mar 22, 2017 01:54 PM IST

    Sell Tata Motors, Glenmark Pharma; buy Colgate Palmolive: Sudarshan Sukhani

    Sudarshan Sukhani of s2analytics.com suggests selling Tata Motors and Glenmark Pharma and advises buying Colgate Palmolive.

  • SC stays Delhi HC order till April 28 against Glenmark Mar 25, 2015 09:00 PM IST

    SC stays Delhi HC order till April 28 against Glenmark

    Glenmark's medicines, Zita and Zita-Met, cost 30 percent less than MSD's Januvia and Janumet, which is due to the customs duty paid by the US firm, the High Court had said and added that "no allegation has been made that MSD on Wednesday sells its drugs at a relatively high price that hinders access to the drug".

Sections
ISO 27001 - BSI Assurance Mark